CNS Disorders  >>  pioglitazone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pioglitazone / Generic mfg.
NCT00242177: Pilot Test of ACTOS in Multiple Sclerosis: Safety and Tolerability

Completed
1
30
US
ACTOS (Pioglitazone)
University of Illinois at Chicago, Takeda Pharmaceuticals North America, Inc.
Multiple Sclerosis, Relapsing-Remitting
 
10/05
NCT03440034: Study of Pioglitazone in Sporadic Inclusion Body Myositis

Completed
1
19
US
Pioglitazone, Actos
Johns Hopkins University
Myositis, Inclusion Body Myositis, Muscular Diseases, Musculoskeletal Disease, Neuromuscular Diseases, Nervous System Diseases
12/20
12/20

Download Options